CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
about
Chemokines and Chemokine Receptors in the Development of Lupus NephritisNaive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.Comparative effects of n-3, n-6 and n-9 unsaturated fatty acid-rich diet consumption on lupus nephritis, autoantibody production and CD4+ T cell-related gene responses in the autoimmune NZBWF1 mouse.CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo.Therapeutic effect of anti-C-X-C motif chemokine 10 (CXCL10) antibody on C protein-induced myositis mouse.CXCR3 in T cell function.Neutrophil gelatinase-associated lipocalin is instrumental in the pathogenesis of antibody-mediated nephritis in mice.The Changing Landscape of Renal InflammationCXCR3+ Regulatory T Cells Control TH1 Responses in Crescentic GN.Chemokine and chemokine receptors in autoimmunity: the case of primary biliary cholangitis.ICOS controls effector function but not trafficking receptor expression of kidney-infiltrating effector T cells in murine lupus.CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality.International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.Plasma CXCL9 elevations correlate with chronic GVHD diagnosis.Plasma biomarkers of risk for death in a multicenter phase 3 trial with uniform transplant characteristics post-allogeneic HCT.CXCR3 ligands: redundant, collaborative and antagonistic functions.Update on crescentic glomerulonephritis.Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation.(5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.Mapping urinary chemokines in human lupus nephritis: Potentially redundant pathways recruit CD4+ and CD8+ T cells and macrophages.CXCR3 Blockade Inhibits T Cell Migration into the Skin and Prevents Development of Alopecia Areata.Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.Inflammatory changes in the central nervous system are associated with behavioral impairment in Plasmodium berghei (strain ANKA)-infected mice.CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.Hypertension in mice lacking the CXCR3 chemokine receptor.Progression of autoimmune hepatitis is mediated by IL-18-producing dendritic cells and hepatic CXCL9 expression in mice.Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands.Tailoring Immune Responses toward Autoimmunity: Transcriptional Regulators That Drive the Creation and Collusion of Autoreactive Lymphocytes.
P2860
Q26741199-0C4F0F96-30BB-4B55-8155-0EE75AEEE6F1Q33730129-46C0BA90-D2E6-4C5F-9E2C-70AD658B48CFQ33778956-6B3D9660-FB3F-48B2-AFE9-32B8A117EB7DQ33864128-D76051C0-774A-4EB2-BC9B-10800DD3F6D9Q33892454-7BE5D68A-2862-4DDF-9126-931350C2198CQ34726782-0754DF45-6B5A-47B7-8323-912DC43A458AQ35886115-EB40F19A-4A80-4C01-AE55-41FC5B825881Q36535196-947E1E31-EDD2-4AB4-9956-5ED3F9A1FD80Q37051984-8F098955-31F6-4FF5-B719-E73BA73D7423Q37072376-0B5040D7-706B-4964-8C6E-FDDA485A1BE3Q37351450-45A1A745-0AF1-4489-9B58-DB3E66FF5E4FQ37358025-DF8E67E4-1E61-417A-BFA3-0E5561BDDD29Q37432097-11C1A8FA-7226-4149-A80C-858EC848E86EQ37535273-52047990-9966-4D42-9511-245088B1BD38Q37585022-EE233B8D-3D9A-46FA-A096-BBCB84B0053DQ37827339-AC976EDF-FF9A-448C-ADFA-178D4D004A24Q38221777-F18CEB09-CACC-43E6-9F99-4984E4E943E3Q38604519-93FF9A20-7381-49F5-9E37-D0AE30C25FADQ38720673-322CD5A3-5068-4543-B1D5-3490C6783000Q38810115-ADC7E296-F257-48D5-BBBE-0473A4598518Q39604573-CCF64421-BE65-4B75-9012-917EBF41DAEEQ42240174-0284C579-1003-4DBC-B6C2-3A0575CB5D43Q42751873-B3424ADD-0128-46AC-A0A7-C05C60B03687Q45931583-BB84655D-2995-47DA-91A1-46EE8C800C5EQ46171920-80C98D2E-4B58-4193-8E71-0399D07FF236Q46206655-F66FDE48-4864-46A5-AD9B-1990B023939FQ49524220-227FD64B-11B2-4212-913F-48F10B81782CQ55030447-9C71CD28-C35A-477B-A60F-306DAD9D9ECE
P2860
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
@ast
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
@en
type
label
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
@ast
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
@en
prefLabel
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
@ast
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease.
@en
P2093
P2860
P356
P1476
CXCL9, but not CXCL10, promotes CXCR3-dependent immune-mediated kidney disease
@en
P2093
Andrew D Luster
Eriya Kikawada
Geraldine C Zeller
Joshua Farber
Julia Menke
Terry K Means
Vicki R Kelley
Xiao R Huang
P2860
P304
P356
10.1681/ASN.2007111179
P50
P577
2008-03-12T00:00:00Z